Marksans Pharma Ltd.

Financial

	Marksans Pharma	Procter&Gamble Healt	Sanofi India
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	25.0 .	n/a	n/a
Number of ANDA's Approved By USFDA	13.0 .	n/a	n/a
R&D as a % of Total Sales	2.2 %	n/a	0.0
Financials
5 yr Average ROE	18.16 %	30.46 %	52.02 %
5yr average Equity Multiplier	1.35	2.99	4.62
5yr Average Asset Turnover Ratio	0.99	0.57	0.47
5yr Avg Net Profit Margin	13.73 %	17.93 %	24.38 %
Price to Book	4.76	18.05	16.47
P/E	30.86	38.59	34.29
5yr Avg Cash Conversion Cycle	69.54 Days	-158.56 Days	4.83 Days
Inventory Days	87.55 Days	36.98 Days	66.8 Days
Days Receivable	69.35 Days	29.14 Days	31.98 Days
Days Payable	84.4 Days	177.2 Days	63.37 Days
5yr Average Interest Coverage Ratio	32.98	337.3	906.11
5yr Avg ROCE	23.15 %	19.93 %	27.19 %
5yr Avg Operating Profit Margin	19.67 %	24.91 %	24.71 %
5 yr average Debt to Equity	0.02	0.0	0.0
5yr CAGR Net Profit	21.8 %	-4.58 %	31.63 %
5yr Average Return on Assets	13.43 %	10.24 %	11.5 %
Shareholdings
Promoter Holding	43.87 %	51.82 %	60.4 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-4.38 %	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	2.91 %	4.1 %	1.07 %

Business

	Marksans Pharma	Procter&Gamble Healt	Sanofi India
Product Wise Break-Up	Product Wise Break-Up Pain Management 44.0 Cough and colds 14.0 Cardiac Science 9.2 Gastro Intestinal 8.5 Central Nervous System (CNS) 8.1 Anti - Diabetes 1.6 Vitamins & Suppliments 0 Anti-Cancer 0 Anti-Hair Fall 0 Antibiotics 0 Anti-allergic 0 Miscellaneous 0 Pharmaceuticals 0 Others 14.6	-	Product Wise Break-Up Anti-Hair Fall 0 Cardiac Science 0 Anti - Diabetes 0 Antibiotics 0 Vitamins & Suppliments 0 Pharmaceutical 100.0 Central Nervous System (CNS) 0 Miscellaneous 0 Pain Management 0 Anti-allergic 0 Anti-Cancer 0 Gastro Intestinal 0 Cough and colds 0
Location Wise Break-Up	Location Wise Break-Up North America 47.1 Europe 39.3 Australia 9.6 India 0 International 0 Domestic 0 Singapore 0 Others 4.0	Location Wise Break-Up Europe 0 Domestic 91.96 Singapore 0 India 0 International 8.04 North America 0 Australia 0	Location Wise Break-Up Europe 0 Domestic 0 Singapore 20.29 India 79.71 International 0 North America 0 Australia 0
Customer Segment	Customer Segment OTC 78.8 Rx 21.2	-	-